$NYMX News Sapient surges on Publicis buyout: Big U.S.

New Post Public Reply Private Reply Replies (0) Message Board

Nov 3, 2014 at 1:27 PM

$NYMX News

Sapient surges on Publicis buyout: Big U.S. stock movers 9:11 a.m. Today - MarketWatch
Friday’s biggest advancers & decliners 5:40 p.m. Dec. 17, 2010 - Kate Gibson
Seven technically strong stocks to buy on a dip 11:15 a.m. May 2, 2007 - Harry Boxer
Nymox: NX-1207 drug has attracted 'serious' interest 1:39 p.m. Jan. 31, 2007 - Gabriel Madway
Nymox: NX-1207 drug has attracted 'serious' interest 1:35 p.m. Jan. 31, 2007 - Gabriel Madway
Tuesday's biggest stock gainers and decliners 6:30 p.m. Dec. 12, 2006 - MarketWatch
Nymox: Review of NX-1207 trial shows no serious side effects 10:09 a.m. June 27, 2006 - Gabriel Madway
Nymox shares up 4.6% at $2.72 10:01 a.m. June 27, 2006 - Gabriel Madway
Nymox: NX-1207 is treatment for benign prostatic hyperplasia 10:00 a.m. June 27, 2006 - Gabriel Madway
Nymox: All trial subjects have completed dosing 9:56 a.m. June 27, 2006 - Gabriel Madway
Nymox: Review of NX-1207 trial shows no serious side effects 9:55 a.m. June 27, 2006 - Gabriel Madway
Nymox Pharma: Positive results on AlzheimAlert from studies 12:42 p.m. June 15, 2006 - Katherine Hunt
Nymox shares down 4.2% at $2.72 12:25 p.m. June 15, 2006 - Gabriel Madway
Nymox reports positive results from AlzheimAlert studies 12:25 p.m. June 15, 2006 - Gabriel Madway
Nymox inks new contract for Alzheimer's test in Korea 11:49 a.m. June 14, 2006 - Katherine Hunt
Nymox shares up 3c at $2.82 11:43 a.m. June 14, 2006 - Katherine Hunt
Terms of Nymox contract with Kyung Min Meditech undisclosed 11:42 a.m. June 14, 2006 - Katherine Hunt
Nymox inks new contract with Kyung Min Meditech in Korea 11:42 a.m. June 14, 2006 - Katherine Hunt
Nymox inks new contract for Alzheimer's test in Korea 11:41 a.m. June 14, 2006 - Katherine Hunt
Nymox Pharma NX-1207 Phase II trial patient dosing complete 8:53 a.m. June 9, 2006 - Carolyn Pritchard

Ad Comm smacks down Sonacare's HIFU device for prostate cancer 12:53 p.m. Oct. 3, 2014 - Seeking Alpha
Encouraging trial results for Nymox prostate cancer drug candidate 12:37 p.m. Sept. 10, 2014 - Seeking Alpha
Encouraging interim results for BPH drug 1:13 p.m. July 22, 2014 - Seeking Alpha
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox 6:51 a.m. July 18, 2014 - TheStreet.com
Enrollment complete in second BPH Phase 3 trial 10:29 a.m. July 15, 2014 - Seeking Alpha
Oversold Conditions For Nymox Pharmaceutical (NYMX) 12:05 p.m. April 30, 2014 - TheStreet.com
The good, the bad and the ugly about Nymox's cancer drug trial 10:32 a.m. April 30, 2014 - Seeking Alpha
4 Biotechnology Stocks to Sell Now 4:30 a.m. Jan. 29, 2014 - InvestorPlace.com
Is Nymox The Next Unknown Biotech Turned High Flyer? 3:39 p.m. July 15, 2013 - Seeking Alpha
In Nymox The Next Unknown Biotech Turned High Flyer? 3:39 p.m. July 15, 2013 - Seeking Alpha
Nymox Pharma: Developing A Potential Long-Term Treatment For BPH 3:43 p.m. April 3, 2013 - Seeking Alpha
Good News for Nymox's Pipeline - Analyst Blog 5:25 p.m. March 21, 2013 - Zacks.com
4 Healthcare Stock Stories for Tuesday Investment Wellness 2:54 p.m. March 19, 2013 - Wall St. Cheat Sheet
Market Close: Big Winners & Losers for March 18, 2013 (CHRY, ATOS, NYMX, PRWT, ULTR, AMBO, EFUT, CNET, PTX, LDK) 2:20 p.m. March 18, 2013 - 247WallSt.com
4 Healthcare Stock Stories to Spark Investment Chatter 7:33 p.m. March 5, 2013 - Wall St. Cheat Sheet
Nymox Tries for Recovery on Safety Profile of NX-1207 for Prostate Cancer 11:02 a.m. March 5, 2013 - 247WallSt.com
11 Must Read Weekend Stock Stories For Monday 11:55 a.m. March 2, 2013 - 247WallSt.com
Hot Stocks: Ten Super Crazy Volume Spikes 1:08 p.m. March 1, 2013 - 247WallSt.com
4 Healthcare Stock Stories for Tuesday Wellness 3:45 p.m. Feb. 19, 2013 - Wall St. Cheat Sheet
8 Biotechnology Stocks to Sell Now 4:00 a.m. Jan. 16, 2013 - InvestorPlace.com

Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 Fail to Meet Primary Efficacy Endpoints 12:01 p.m. Nov. 2, 2014 - GlobeNewswire
Nymox Announces Positive Prostate Cancer 8 Month Clinical Trial Results 8:31 a.m. Sept. 10, 2014 - GlobeNewswire
Nymox Reports Second Quarter 2014 Financial Results 8:31 a.m. Aug. 11, 2014 - GlobeNewswire
Press Release Issued Under the Early Warning System/Sale of Shares of Nymox Pharmaceutical Corporation 4:01 p.m. Aug. 6, 2014 - GlobeNewswire
Nymox Announces Positive Efficacy Results in Phase 3 Repeat Injection Trial of NX-1207 for BPH 8:30 a.m. July 22, 2014 - GlobeNewswire
Nymox Announces Completion of Enrollment for Second BPH Re-Injection Study 8:30 a.m. July 15, 2014 - GlobeNewswire
Nymox Reports Positive Update on Nerve Sparing and Sexual Function Preservation in Men Treated With NX-1207 9:01 a.m. June 17, 2014 - GlobeNewswire
Nymox Reports Positive New Safety Study Data for Phase 3 BPH Drug 9:16 a.m. June 11, 2014 - GlobeNewswire
Nymox Reports New Results on Favorable Side Effect Profile of NX-1207 Treatment 8:51 a.m. May 21, 2014 - GlobeNewswire
Nymox Reports First Quarter 2014 Financial Results 8:46 a.m. May 15, 2014 - GlobeNewswire
Nymox Pharmaceutical Late- Stage Clinical Trials Substantiating Investor Interest; Analyst Report by BrokerBank Securities, Inc. 6:00 a.m. May 14, 2014 - PR Newswire - PRF
Nymox Reports Positive Results Showing That NX-1207 Treatment for Prostate Cancer Does Not Affect Testosterone Levels 8:46 a.m. May 13, 2014 - GlobeNewswire
Nymox Announces Completion of Second Pivotal Phase 3 NX-1207 Trial for BPH 9:31 a.m. May 8, 2014 - GlobeNewswire
Nymox Announces Positive New Prostate Cancer Clinical Trial Results 9:01 a.m. May 6, 2014 - GlobeNewswire
Nymox Reports Top-Line Results for Localized Prostate Cancer Study 8:32 a.m. April 30, 2014 - GlobeNewswire
Nymox Reports 2013 Financial Results 12:00 p.m. March 14, 2014 - GlobeNewswire
Nymox Announces Appointment of Andre Monette 2:00 p.m. Feb. 5, 2014 - GlobeNewswire
Nymox Provides Update on NX-1207 Phase 3 BPH and Phase 2 Prostate Cancer Clinical Trial Activities 11:30 a.m. Jan. 28, 2014 - GlobeNewswire
Nymox Closes Recruitment for NX-1207 Phase 2 Prostate Cancer Trial 10:00 a.m. Jan. 13, 2014 - GlobeNewswire
Madison Capital Corporation Announces Proposed Qualifying Transaction 12:36 p.m. Nov. 21, 2013 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TDS and Array Set for Q3 Results Amid Market Curiosity

The Anticipation Builds for TDS and Array's Q3 Results Financial markets are buzzing like a caffeine-fueled trading floor about the upcoming third quarter results from Telephone and Data Systems, Inc. (NYSE: TDS) and its partner in digital endeavors, Array Digital Infrastructure, Inc. (NYSE: AD). Set to go live with their numbers on November 6, 2026, these companies are...

Intestinal Worms: New Science and Old Challenges

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

ZKONG, Hagebau Push ESLs in European Retail Revamp

ESLs: The Next Step in Retail Revamp Here’s the scoop: ZKONG and hagebau are making waves in the retail scene over in Germany. They’re bringing in Electronic Shelf Labels (ESLs) to kick traditional price tags to the curb. What started as a shake-up in supermarkets now rolls into the world of home improvement retail—headline by hagebaumarkt in Selb after nearly half...

Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...

Thai Wellness Shines at Global Summit in Phuket

The New Face of Luxury: Healing and Wellness Thailand's gearing up for a spotlight moment on the global stage, and they're flaunting their wellness card at the upcoming Global Wellness Summit (GWS) 2026 in Phuket. From November 10-13, the world's wellness bigwigs will descend on this tropical locale to experience firsthand what Thailand’s calling 'Healing is the New...

Generational Happiness: Keio Study Shakes Norms

Happiness Across Generations: New Light from Japan Think happiness is just a personal journey? Well, it turns out there's more to the story when you dive into family ties. A study from Keio University in Japan shakes things up by finding that happiness has a unique way of passing down from parent to child, showing a stronger grip across generations than general or mental...

KickHouse Partners with Sam Alvey for Glove Line Launch

KickHouse Pounces with New Fighter Partnership Looks like KickHouse isn't playing games, folks. They've teamed up with fighter Sam Alvey to launch a new boxing glove line. You got your Warbird, your Desert Ghost, and your Night Ops gloves—names straight out of a war zone. These 16-ounce hammers are out now, and they kickstart a broader gear lineup custom-built for Alvey...

European Doctors Explore Chinese Aesthetic Innovations

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...

Hot Chili Sizzles with La Verde Copper Drill Gains

Big Copper Moves at La Verde: What's New? Look, when it comes to copper, Hot Chili Limited is throwing down some serious markers. You see, their La Verde project is turning into a hotbed of activity thanks to their latest drilling revelations. They've managed to confirm a second porphyry center, which is like finding another gold mine, except with copper. This essentially...

FDA Greenlights VELO: A Turning Point for Reynolds?

FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...